Treatment of Shiga Toxin-Producing Infections
Primary Treatment Approach
- Aggressive fluid management is the only proven effective treatment for STEC infections, with early parenteral volume expansion crucial to prevent HUS development 1
- For mild to moderate dehydration: Use reduced osmolarity oral rehydration solution (ORS) as first-line therapy 1, 2
- For severe dehydration, shock, altered mental status, or ORS failure: Administer isotonic intravenous fluids (lactated Ringer's or normal saline) 1, 2
Critical Monitoring Requirements
- Close surveillance for HUS development is mandatory, particularly in children under 5 years who face the highest risk 1
- Monitor specifically for the HUS triad: thrombocytopenia, hemolytic anemia, and renal failure 1
- Continue monitoring even after diarrhea resolves, as HUS can develop days after initial symptoms 3
Diagnostic Considerations
- Prompt and accurate diagnosis enables appropriate supportive care and prevents inappropriate antibiotic use 1
- All stools from patients with acute community-acquired diarrhea should be simultaneously cultured for E. coli O157:H7 and tested with Shiga toxin assays 3, 4
- Testing should occur regardless of patient age, season, or presence of blood in stool 3
- Specimens should be collected as soon as possible after diarrhea onset, while acutely ill, and before any antibiotic administration 5, 6